Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study
Article 2013 en
Authors
MB
Martina Bonifazi
MF
Matteo Franchi
MR
Marta Rossi
Abstract
1 min read
Cardiotoxicity of trastuzumab varies considerably across subgroups of patients. The long-term safety profile was less favorable than in the largest clinical trial. Strategies to reduce cardiotoxicity in high-risk women should be investigated.
Martina Bonifazi, Matteo Franchi, Marta Rossi, Alberto Zambelli, Lorenzo Moja, Antonella Zambon, Giovanni Corrao, Carlo La Vecchia, Carlo Zocchetti, Eva Negri
Eva Negri, Alberto Zambelli, Matteo Franchi, Marta Rossi, Martina Bonifazi, Giovanni Corrao, Antonella Zambon, Lorenzo Moja, Carlo Zocchetti, Carlo La Vecchia
Seung Woo Han, S R Lee, E K Choi, Bum‐Soo Kim, Kyungdo Han, Jae-Woon Choi, Kyung‐Yul Lee, Hyo‐Jeong Ahn, Sun U. Kwon, Seung Min Oh, Professor Gregory Lip
Sònia Palomeras, Ángel Díaz‐Lagares, Gemma Viñas, Fernando Setién, Humberto J. Ferreira, Glòria Oliveras, Ana B. Crujeiras, A. Hernández, David H. Lum, Alana L. Welm, Manel Esteller, Teresa Puig
Discussion(0)
No comments yet. Be the first to comment.